[1] |
LIANG Damin, YANG Zhengjiu, ZHANG Ziping, QIAN Jing, MAO Chaokun.
Study on the effect and mechanism of kaempferol in reversing drug-resistant Bel-7402/5-Fu cells
[J]. Tianjin Medical Journal, 2024, 52(9): 900-906.
|
[2] |
MA Jiajia, ZHANG Yaping, YANG Bin, ZHAO Meiqi, JIANG Lu, HUANG Xiaoyu, FAN Luchang, WANG Fengmei.
Mechanism study of ATOX1 promoting biological behavior of hepatocellular carcinoma cells through JAK2/STAT3 pathway
[J]. Tianjin Medical Journal, 2024, 52(9): 907-912.
|
[3] |
ZHU Wenzhi, QIU Qian, TAN Hongyu.
The impact of preoperative anxiety on anesthesia and postoperative recovery in patients with liver cancer
[J]. Tianjin Medical Journal, 2024, 52(7): 762-765.
|
[4] |
ZHU Gangming, DONG Yongde, ZHU Ruiting, TAN Yuanman, TAO Juan, LIU Xiao, CHEN Decheng, YANG Gai.
The value of magnetic resonance relaxation time quantitative imaging in predicting molecular subtypes of invasive ductal carcinoma
[J]. Tianjin Medical Journal, 2024, 52(7): 770-774.
|
[5] |
HUO Jingchen, WANG Yue, LI Hua, QIU Rong, SU Jingwei, WANG Zhuofan, YANG Jie.
Predictive value of systemic immune inflammation index (SII) on long-term survival of patients with stage III squamous lung cancer treated with radical radiotherapy
[J]. Tianjin Medical Journal, 2024, 52(6): 634-638.
|
[6] |
ZHANG Caidie, JIN Yan, ZHANG Dede.
The anti-tumor effect of Runfei Yishen drink on lung cancer bearing rats and its impact on tumor immune microenvironment
[J]. Tianjin Medical Journal, 2024, 52(4): 362-366.
|
[7] |
WU Qian, WANG Yi, CHEN Nian, ZHOU Kai, TIAN Xin, XU Hui, GOU Xiaoxia.
Effect of induction chemotherapy on immune function and inflammatory indicators in patients with nasopharyngeal carcinoma
[J]. Tianjin Medical Journal, 2024, 52(4): 397-402.
|
[8] |
QIN Aiying, CHEN Jing, SHAN Fengxiao, LU Hanjie, WU Yang.
The correlation between expression of lncRNA MIR503HG and Wnt1 in non-small cell lung cancer tissue and patient survival within 5 years after surgery
[J]. Tianjin Medical Journal, 2024, 52(4): 403-408.
|
[9] |
XU Dan, LIU Xia, ZHONG Diansheng.
Frst-line treatment of Zorifertinib in EGFR-mutant NSCLC with CNS metastases: a report of two cases
[J]. Tianjin Medical Journal, 2024, 52(3): 315-318.
|
[10] |
SUN Ruixue, LIU Xiaoxiao, YUE Xinyi, YANG Dongmei, REN Luning, WANG Fei, DU Hongyang.
Predictive value of preoperative blood inflammatory markers for recurrence risk of basal cell carcinoma
[J]. Tianjin Medical Journal, 2024, 52(12): 1274-1277.
|
[11] |
SUN Chuangxin, LI Gang.
Role of NID1 in angiogenesis of clear cell renal cell carcinoma
[J]. Tianjin Medical Journal, 2024, 52(10): 1009-1013.
|
[12] |
JIANG Zhongmin, ZHANG Chunyan, LIU Min, ZHENG Jie, LI Yanxia, REN Qingcuo, MENG Wei, LIU Xiaozhi.
Construction of micropapillary lung adenocarcinoma organoids and screening of targeted drugs
[J]. Tianjin Medical Journal, 2024, 52(1): 22-27.
|
[13] |
LIU Guoqi, LI Chengcheng, LIU Shengju, ZHU Liying.
Emodin regulates histone acetylation to promote pyroptosis and apoptosis of HpG2 hepatoma cells
[J]. Tianjin Medical Journal, 2024, 52(1): 56-60.
|
[14] |
ZHANG Zhenhua, FU Wei, LIU Weiliang, LI Junyan, HUANG Tao, HU Hui, FAN Zhigang.
Application of PET/CT radiomics combined with LncRNA-DGCR5 in precision medicine of NSCLC
[J]. Tianjin Medical Journal, 2023, 51(9): 1011-1015.
|
[15] |
ZHANG Tianwei, ZHANG Jinbiao, ZHANG Yan, MING Hui, ZHANG Peng, NIE Dong.
Changes and clinical significance of serum circPVT1 and miR-486-5p levels before and after radiotherapy for advanced NSCLC
[J]. Tianjin Medical Journal, 2023, 51(9): 998-1001.
|